Celularity Inc. (CELU) NASDAQ

Currency In USD

AD

Valuation

Market Cap28.41M
Enterprise Value63.14M
P/E Ratio-0.22
PEG Ratio0.01
Price/Sales Ratio0.87
Price/Book Ratio-0.54
Enterprise/Revenue2.18
Enterprise/EBITDA-0.75

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-3.45
Operating Margin-2.31
AD

Management Effectiveness

Return On Assets-0.85
Return On Equity4.11

Income Statement

Revenue26.55M
Revenue/Share1.04
Gross Profit20.19M
EBITDA-77.66M
Net Income-91.8M
Diluted EPS-3.59

Balance Sheet

Total Cash6.18M
Total Cash/Share0.24
Total Debt40.9M
Total Debt/Equity-1.07
Current Ratio0.15
Book Value Per Share-1.49

Price History

52-Week Change-78.89
52-Week High4.01
52-Week Low0.56
Moving Average 50 Days0.72
Moving Average 200 Days1.15

Statistics

Average Volume103,335
Shares Outstanding28.95M
% Held by Institutions8.6

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateFebruary 29, 2024
AD